The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival

被引：0
|
作者：
Emine Acar
Özhan Özdoğan
Ayşegül Aksu
Erkan Derebek
Recep Bekiş
Gamze Çapa Kaya
机构：
[1] İzmir Kâtip Çelebi University,Department of Nuclear Medicine, Ataturk Training and Research Hospital
[2] Dokuz Eylul University,Department of Translational Oncology, Institute of Health Sciences
[3] Dokuz Eylul University,Department of Nuclear Medicine, School of Medicine
来源：
Annals of Nuclear Medicine | 2019年 / 33卷
关键词：
PSMA; MTV; TLG; Tumor volume; Precision medicine; Theranostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 688
页数：7
相关论文
共 50 条
  • [31] Early initiation of Lu-177 PSMA radioligand therapy prolongs overall survival in metastatic prostate cancer
    Kulkarni, Harshad
    Schuchardt, Christiane
    Singh, Aviral
    Langbein, Thomas
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [32] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Kotchakorn Chatachot
    Shuichi Shiratori
    Tawatchai Chaiwatanarat
    Kitiwat Khamwan
    Annals of Nuclear Medicine, 2021, 35 : 1193 - 1202
  • [33] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Chatachot, Kotchakorn
    Shiratori, Shuichi
    Chaiwatanarat, Tawatchai
    Khamwan, Kitiwat
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (11) : 1193 - 1202
  • [34] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Philipp E. Hartrampf
    Franz-Xaver Weinzierl
    Andreas K. Buck
    Steven P. Rowe
    Takahiro Higuchi
    Anna Katharina Seitz
    Hubert Kübler
    Andreas Schirbel
    Markus Essler
    Ralph A. Bundschuh
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
  • [35] Streamlining Parameter Dimensionality in a PBPK Model for [177Lu]Lu-PSMA I&T Radioligand Therapy using Bayesian Parameter Estimation
    Orlov, C.
    Yousefzadeh-Nowshahr, E.
    Begum, N. J.
    Vasic, V.
    Beer, A. J.
    Glatting, G.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S208 - S209
  • [36] Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received 177Lu PSMA I&T therapy
    Bulbul, Ogun
    Unek, Ilkay Tugba
    Kefi, Aykut
    Tuna, Emine Burcin
    Bekis, Recep
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (03) : 229 - 239
  • [37] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Buck, Andreas K.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Schirbel, Andreas
    Essler, Markus
    Bundschuh, Ralph A.
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3269 - 3276
  • [38] Identification of [177Lu]Lu-PSMA I&T, [177Lu]LuCl3 and [177Lu] Lu-DTPA by a single reversed-phase TLC
    Cucchi, C.
    Bogni, A.
    Mainente, M.
    Beretta, C.
    Kirienko, M.
    Seregni, E.
    Pascali, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S666 - S666
  • [39] Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapy using Deep Learning
    Xue, Song
    Gafita, Andrei
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Rominger, Axel
    Shi, Kuangyu
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [40] Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapyusing Deep Learning
    Xue, S.
    Gafita, A.
    Zhao, Y.
    Afshar-Oromieh, A.
    Eiber, M.
    Rominger, A.
    Shi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S237 - S238
12345